[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1021/bi00365a020; PubMed=3021205 [NCBI, ExPASy, EBI, Israel, Japan]
Leytus S.P.,
Kurachi K.,
Sakariassen K.S.,
Davie E.W.;
"Nucleotide sequence of the cDNA coding for human complement C1r.";
Biochemistry 25:4855-4863(1986).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-152.
PubMed=3030286 [NCBI, ExPASy, EBI, Israel, Japan]
Journet A.,
Tosi M.;
"Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.";
Biochem. J. 240:783-787(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-131; LEU-152; TYR-163; LYS-184 AND ARG-261.
DOI=10.1046/j.1469-1809.2003.00019.x; PubMed=12914573 [NCBI, ExPASy, EBI, Israel, Japan]
Nakagawa M.,
Yuasa I.,
Irizawa Y.,
Umetsu K.;
"The human complement component C1R gene: the exon-intron structure and the molecular basis of allelic diversity.";
Ann. Hum. Genet. 67:207-215(2003).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-152.
TISSUE=Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
PROTEIN SEQUENCE OF 18-463.
PubMed=3036070 [NCBI, ExPASy, EBI, Israel, Japan]
Arlaud G.J.,
Willis A.C.,
Gagnon J.;
"Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.";
Biochem. J. 241:711-720(1987).
|
[6]
|
PROTEIN SEQUENCE OF 464-705.
DOI=10.1021/bi00277a003; PubMed=6303394 [NCBI, ExPASy, EBI, Israel, Japan]
Arlaud G.J.,
Gagnon J.;
"Complete amino acid sequence of the catalytic chain of human complement subcomponent C1-r.";
Biochemistry 22:1758-1764(1983).
|
[7]
|
PROTEIN SEQUENCE OF 152-186, AND HYDROXYLATION.
DOI=10.1016/0014-5793(87)80205-3; PubMed=2820791 [NCBI, ExPASy, EBI, Israel, Japan]
Arlaud G.J.,
van Dorsselaer A.,
Bell A.,
Mancini M.,
Aude C.,
Gagnon J.;
"Identification of erythro-beta-hydroxyasparagine in the EGF-like domain of human C1r.";
FEBS Lett. 222:129-134(1987).
|
[8]
|
PROTEIN SEQUENCE OF 133-137; 187-211 AND 609-613, AND PHOSPHORYLATION.
DOI=10.1016/0014-5793(96)00403-6; PubMed=8635594 [NCBI, ExPASy, EBI, Israel, Japan]
Pelloux S.,
Thielens N.M.,
Hudry-Clergeon G.,
Petillot Y.,
Filhol O.,
Arlaud G.J.;
"Identification of a cryptic protein kinase CK2 phosphorylation site in human complement protease Clr, and its use to probe intramolecular interaction.";
FEBS Lett. 386:15-20(1996).
|
[9]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125; ASN-221 AND ASN-514, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[10]
|
STRUCTURE BY NMR OF 140-192.
DOI=10.1021/bi971851v; PubMed=9477945 [NCBI, ExPASy, EBI, Israel, Japan]
Bersch B.,
Hernandez J.-F.,
Marion D.,
Arlaud G.J.;
"Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family.";
Biochemistry 37:1204-1214(1998).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 307-702.
DOI=10.1093/emboj/21.3.231; PubMed=11823416 [NCBI, ExPASy, EBI, Israel, Japan]
Budayova-Spano M.,
Lacroix M.,
Thielens N.M.,
Arlaud G.J.,
Fontecilla-Camps J.-C.,
Gaboriaud C.;
"The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.";
EMBO J. 21:231-239(2002).
|
[12]
|
X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 375-702.
DOI=10.1016/S0969-2126(02)00881-X; PubMed=12429092 [NCBI, ExPASy, EBI, Israel, Japan]
Budayova-Spano M.,
Grabarse W.,
Thielens N.M.,
Hillen H.,
Lacroix M.,
Schmidt M.,
Fontecilla-Camps J.-C.,
Arlaud G.J.,
Gaboriaud C.;
"Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism.";
Structure 10:1509-1519(2002).
|
[13]
|
VARIANT LEU-152.
DOI=10.1093/hmg/3.1.217-a; PubMed=8162045 [NCBI, ExPASy, EBI, Israel, Japan]
Nothen M.M.,
Dewald G.;
"A common amino acid polymorphism in complement component C1R.";
Hum. Mol. Genet. 3:217-217(1994).
|
|
ExPASy Home page
SIB Switzerland
